Rationale for Japanese encephalitis vaccination in short-term travellers to endemic areas

被引：2

作者：

Charoensakulchai, Sakarn ^{[1
]}

Singhasenee, Pattaratida ^{[1
]}

Matsee, Wasin ^{[1
,2
]}

Caumes, Eric ^{[3
]}

Pisutsan, Phimphan ^{[1
,2
]}

机构：

[1] Mahidol Univ, Hosp Trop Dis, Fac Trop Med, Thai Travel Clin, Bangkok 10400, Thailand

[2] Mahidol Univ, Travel Med Res Unit, Mahidol Vivax Res Unit, Bangkok 10400, Thailand

[3] Hosp Hotel Dieu, Dept Infect Dis, 1 Pl Parvis Notre Dame, F-75004 Paris, France

来源：

JOURNAL OF TRAVEL MEDICINE | 2024年 / 31卷 / 02期

关键词：

Japanese encephalitis vaccine; short-term travellers; low risk; immunogenicity; cost-benefit; high transmission; VACCINES; LIVE;

D O I：

10.1093/jtm/taae003

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Although the Japanese encephalitis (JE) vaccine is typically strongly recommended for long-term high-risk travellers, some cases of JE infections have been reported amongst short-term travellers with seemingly low risk. This article underscores the advantages and reasoning behind JE vaccination for this particular group of travellers.

引用

页数：4

共 15 条

[1]

[Anonymous], 1993, MMWR RECOMM REP, V42, P1

[2]

Bernard P, 1998, PRESSE MED, V27, P1327

[3] Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk [J].

Buhl, Mads R. ;

Lindquist, Lars .

JOURNAL OF TRAVEL MEDICINE, 2009, 16 (03) :217-219

[4]

Furuya-Kanamori L., 2021, J TRAVEL MED, V28

[5]

Furuya-Kanamori L., 2022, J TRAVEL MED, V30

[6] Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973-2008 [J].

Hills, Susan L. ;

Griggs, Anne C. ;

Fischer, Marc .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 82 (05) :930-936

[7] A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellers [J].

Lau, Colleen L. ;

Mills, Deborah J. ;

Mayfield, Helen ;

Gyawali, Narayan ;

Johnson, Brian J. ;

Lu, Hongen ;

Allel, Kasim ;

Britton, Philip N. ;

Ling, Weiping ;

Moghaddam, Tina ;

Furuya-Kanamori, Luis .

JOURNAL OF TRAVEL MEDICINE, 2023, 30 (07)

[8] Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis [J].

Leder, K. ;

Chen, L. H. ;

Wilson, M. E. .

VACCINE, 2012, 30 (15) :2600-2604

[9]

Mills DJ., 2021, J TRAVEL MED, V28

[10] Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections [J].

Monath, TP ;

McCarthy, K ;

Bedford, P ;

Johnson, CT ;

Nichols, R ;

Yoksan, S ;

Marchesani, R ;

Knauber, M ;

Wells, KH ;

Arroyo, J ;

Guirakhoo, F .

VACCINE, 2002, 20 (7-8) :1004-1018

← 1 2 →